Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US49876K1034
Filter zurücksetzen
Sa., 26.07.2025       Greenland Mines
US49876K1034

Company to Pursue Technologies to Improve Brain Function, Muscle Strength, Bone Health, and Other Longevity Indicators NEW YORK, July 25, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) (the "Company" or "Klotho") announced that it is evaluating the acquisition of several complementary technologies aimed at supporting healthy brain...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Do., 24.07.2025       Greenland Mines
US49876K1034

Company to Pursue Technologies to Improve Muscle Strength, Bone Health, and Other Longevity Indicators NEW YORK, July 24, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) (the "Company" or "Klotho") announced today that it is evaluating the acquisition of several complementary technologies aimed at supporting healthy brain function,...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Di., 22.07.2025       Greenland Mines
US49876K1034

NEW YORK, July 22, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), announced that it is partnering with AAVnerGene Inc. (AAVnerGene), a Rockville, MD-based innovation-driven biotech renowned for its transformative technologies in AAV manufacturing and tissue-targeted delivery. ...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Mi., 16.07.2025       Greenland Mines
US49876K1034

Klotho Neurosciences Maintains Listing on the NASDAQ NEW YORK, July 16, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. ("Klotho" or the "Company") (NASDAQ: KLTO), a gene and cell therapy company focused on the treatment of neurodegenerative and other aging-related diseases, today announced that it had received a notification letter from The NAS...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Do., 10.07.2025       Greenland Mines
US49876K1034

NEW YORK, July 10, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO), a gene and cell therapy company focused on the treatment of neurodegenerative and other aging-related diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company's novel secreted-Klotho (s-KL) promot...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Mo., 30.06.2025       Greenland Mines
US49876K1034

NEW YORK, June 30, 2025 /CNW/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) today announced that it is moving forward with manufacturing and process development work in preparation for clinical trials of KLTO-202, its investigational gene therapy for amyotrophic lateral sclerosis (ALS)....
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Mo., 30.06.2025       Greenland Mines
US49876K1034

NEW YORK, June 30, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) today announced that it is moving forward with manufacturing and process development work in preparation for clinical trials of KLTO-202, its investigational gene therapy for amyotrophic lateral sclerosis (ALS). A unique RNA splice variant of the human gene called...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Mo., 30.06.2025       Greenland Mines
US49876K1034

NEW YORK, June 30, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) today announced that it is moving forward with manufacturing and process development work in preparation for clinical trials of KLTO-202, its investigational gene therapy for amyotrophic lateral sclerosis (ALS)....
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Mo., 30.06.2025       Greenland Mines
US49876K1034

NEW YORK, June 30, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) today announced that it is moving forward with manufacturing and process development work in preparation for clinical trials of KLTO-202, its investigational gene therapy for amyotrophic lateral sclerosis (ALS). A unique RNA splice variant of the human gene called...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Di., 24.06.2025       Greenland Mines
US49876K1034

NEW YORK, June 24, 2025 /PRNewswire/ -- Klotho Neuroscience, Inc. (NASDAQ: KLTO), a US-based biogenetics company developing cell and gene- based treatments to address neurological conditions, including ALS, Alzheimer's Disease (AD) and Parkinson's Disease (PD), has announced that it is partnering with Drs. Makoto Suzuki, Craig and Bradley Willcox...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Di., 24.06.2025       Greenland Mines
US49876K1034

NEW YORK, June 24, 2025 /CNW/ -- Klotho Neuroscience, Inc. (NASDAQ: KLTO), a US-based biogenetics company developing cell and gene- based treatments to address neurological conditions, including ALS, Alzheimer's Disease (AD) and Parkinson's Disease (PD), has announced that it is partnering with Drs. Makoto Suzuki, Craig and Bradley Willcox, Richa...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Di., 24.06.2025       Greenland Mines
US49876K1034

NEW YORK, June 24, 2025 /PRNewswire/ -- Klotho Neuroscience, Inc. (NASDAQ: KLTO), a US-based biogenetics company developing cell and gene- based treatments to address neurological conditions, including ALS, Alzheimer's Disease (AD) and Parkinson's Disease (PD), has announced that it is partnering with Drs. Makoto Suzuki, Craig and Bradley Willcox...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Di., 24.06.2025       Greenland Mines
US49876K1034

NEW YORK, June 24, 2025 /PRNewswire/ -- Klotho Neuroscience, Inc. (NASDAQ: KLTO), a US-based biogenetics company developing cell and gene- based treatments to address neurological conditions, including ALS, Alzheimer's Disease (AD) and Parkinson's Disease (PD), has announced that it is partnering with Drs. Makoto Suzuki, Craig and Bradley Willcox...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Mi., 18.06.2025       Greenland Mines
US49876K1034

Key highlights of the announcement include: Elimination of Future Dilution: The Company will no longer be required to issue new common stock to SkyBell, which would have resulted in SkyBell owning 90% of the Company—substantially diluting existing shareholders.No Liability: Neither Klotho nor SkyBell will incur any liability as a result of the te...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Mo., 16.06.2025       Greenland Mines
US49876K1034

Highlights: Over $11 Million Raised: Proceeds were generated through the exercise of existing warrants. Chardan Capital Markets was the exclusive financial advisor in connection with public warrant exercises.Update on NASDAQ Compliance: Klotho believes it now exceeds the stockholders' equity thresholds required to remain in compliance with NASDAQ...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Mo., 09.06.2025       Greenland Mines
US49876K1034

Recent clinical and pre-clinical studies and analysis indicates the potential to increase lifespan and reduce age-associated degeneration in multiple organ systems has be realized with a focus on the human gene called Klotho. NEW YORK, June 9, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biogenetics company announc...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Mi., 08.01.2025       Greenland Mines
US49876K1034

Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P Morgan Healthcare Week in San Francisco...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Mo., 09.12.2024       Greenland Mines
US49876K1034

Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences’ Scientific Advisory Board...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Di., 03.12.2024       Greenland Mines
US49876K1034

Former Merck USA President Joins Klotho Neurosciences’ Board of Directors...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Mi., 23.10.2024       Greenland Mines
US49876K1034

Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Di., 15.10.2024       Greenland Mines
US49876K1034

Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Mo., 30.09.2024       Greenland Mines
US49876K1034

Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink
Mo., 30.09.2024       Greenland Mines
US49876K1034

Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)...
Zur Nachricht
Greenland Mines
Charts & Research Termsheets Terminal
Permalink